Tourmaline Bio Inc.

12.39
-0.70 (-5.35%)
At close: Mar 03, 2025, 3:59 PM
12.33
-0.48%
After-hours: Mar 03, 2025, 04:00 PM EST

Tourmaline Bio Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 140.73M 8.26M 150K 17.59M 38.98M
Short-Term Investments 62.23M n/a 225.36M 131.9M n/a
Long-Term Investments n/a 216K n/a n/a n/a
Other Long-Term Assets 974K n/a 104K 14K 21K
Receivables n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a
Other Current Assets 5.92M 54K n/a 1.26M 1.82M
Total Current Assets 208.87M 8.31M 150K 150.75M 40.79M
Property-Plant & Equipment 447K 570K 4.8M 2.01M 1.13M
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 1.42M 786K 4.91M 2.03M 1.15M
Total Assets 210.29M 9.1M 150K 152.78M 41.94M
Account Payables 1.07M 401K 194K 767K n/a
Deferred Revenue n/a 799.04K 31.97K n/a n/a
Short-Term Debt 221K 162K 150K n/a n/a
Other Current Liabilities 3.71M 800K 32K 2.64M 2.29M
Total Current Liabilities 5M 1.36M 376K 3.4M 2.29M
Long-Term Debt 194K 342K n/a n/a n/a
Other Long-Term Liabilities 57K 27.13M n/a 1.37M 63K
Total Long-Term Liabilities 251K 27.47M 626K 1.37M 63K
Total Liabilities 5.25M 28.83M 376K 4.77M 2.35M
Total Debt 415K 504K 150K n/a n/a
Common Stock 2K n/a 4K 1K 3K
Retained Earnings -62.05M -19.93M -226K -43.01M -20.31M
Comprehensive Income 67K n/a -78K -13K -3K
Shareholders Equity 205.04M -19.73M -226K 148M 39.59M
Total Investments 62.23M 216K 225.36M 131.9M n/a